Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986660 · ClinicalTrials.gov registry record · Phase 1
Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults
A Phase 1 study, sponsored by Strategic Science & Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01986660 is a Phase 1 study that has completed, run by Strategic Science & Technologies. The registered enrollment target is 14 participants.
The verdict
NCT01986660, a Phase 1 study, has completed, sponsored by Strategic Science & Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and eliminated by the body under defined maximum dosing conditions and to evaluate the safety under these conditions.
Interventions
- DRUG Ibuprofen Cream (SST-0225)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-10 |
| Est. Completion | 2013-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986660
The ClinicalTrials.gov registry entry for NCT01986660 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Strategic Science & Technologies, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ibuprofen Cream (SST-0225) is the first listed.
NCT01986660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986660 about?
NCT01986660 is a clinical study titled "Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults". The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and eliminated by the body under defined maximum dosing conditions and to evaluate the safety under these conditions.
What is the current status of trial NCT01986660?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2013-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01986660?
The interventions under investigation include: Ibuprofen Cream (SST-0225) (DRUG).
Who is sponsoring clinical trial NCT01986660?
This trial is sponsored by Strategic Science & Technologies, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.